50 reports

This can be attributed to the high prevalence of diseases such as HIV/ AIDS, hepatitis, Ebola, caused by viral infections.

  • Musculoskeletal Disorder
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.

HIV/ AIDS, rheumatoid arthritis, hepatitis B and psychiatric disorders.

  • Musculoskeletal Disorder
  • China
  • Demand
  • Bayer AG
  • Yunnan Baiyao Group Co., Ltd.

HIV/ AIDS, rheumatoid arthritis, hepatitis B and psychiatric disorders.

  • Musculoskeletal Disorder
  • China
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.

FOR HIV/ AIDS (PHASE III), ZORCELL FOR PSORIASIS (PHASE ## RemuneX™ is a trademark of Immune Response BioPharma ## Zorcell™ is a trademark of Immune Response BioPharma ## CrohnsVax™ is a trademark of Immune Response BioPharma ## ##.

  • Musculoskeletal Disorder
  • North America
  • United States
  • AbbVie Inc.
  • Astellas Pharma Inc.

PRIOR TO JOINING GLOBALDATA, NATASHA WORKED AS AN EPIDEMIOLOGIST FOR THREE YEARS IN THE HIV/ AIDS SURVEILLANCE PROGRAM AT THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH (MDPH).

  • Musculoskeletal Disorder
  • France
  • Italy
  • United States
  • Forecast

It concentrates its R& D efforts in the area of diseases with significant unmet medical needs: HIV/ AIDS, oncology, hepatitis, immunologic disorders, and cardiovascular and fibrotic disease.

  • Musculoskeletal Disorder
  • Anthera Pharmaceuticals, Inc.
  • Biogen Idec Inc.
  • ImmuPharma plc
  • Merck Serono S.A.

The company' s target therapeutic areas include rheumatoid arthritis, HIV/ AIDS, respiratory infections, cancer, diabetes, men' s and women' s health, and genetic conditions.

  • Musculoskeletal Disorder
  • North America
  • United States
  • Forecast
  • Thermo Fisher Scientific, Inc.

The company also develops anti-HIV vaccines.

  • Cancer Immunotherapy
  • Musculoskeletal Disorder
  • Oncology
  • Therapy
  • Merck & Co., Inc.

The company manufactures prescription pharmaceuticals in several therapeutic areas, including cancer, HIV/ AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.

  • Genitourinary System Disease
  • Musculoskeletal Disorder
  • World
  • Forecast
  • Aurinia Pharmaceuticals Inc.

ELISA is widely used for the diagnosis of HIV/ AIDS (human immunodeficiency virus-acquired immunodeficiency syndrome), owing to the highly-sensitive nature of these assays.

  • Immunochemistry Test
  • Musculoskeletal Disorder
  • World
  • Market Size
  • Thermo Fisher Scientific, Inc.
  • PIPELINE BY IMMUNE RESPONSE BIOPHARMA INC, H2 2017

Its products are used to treat multiple sclerosis, sepsis shock, HIV AIDS, rheumatoid arthritis, Crohns disease and psoriasis.

  • Chronic Disease
  • Musculoskeletal Disorder
  • Therapy
  • United States
  • Product Initiative
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Musculoskeletal Disorder
  • Pharmaceutical
  • World
  • Official Title
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database

Hoffmann-La Roche Ltd Merck & Co Inc ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## Eli Lilly and Co ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## GlaxoSmithKline Plc DSM Biologics Holdings Inc ## ## ## ## ## ##

  • Musculoskeletal Disorder
  • Therapy
  • World
  • Product Initiative
  • Amgen Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Musculoskeletal Disorder
  • Therapy
  • World
  • Product Initiative
  • GOUTY ARTHRITIS (GOUT) - PIPELINE BY TEIJIN PHARMA LTD, H2 2017
  • GOUTY ARTHRITIS (GOUT) - PIPELINE BY SWEDISH ORPHAN BIOVITRUM AB, H2 2017

Gouty Arthritis (Gout) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Gouty Arthritis (Gout) - Pipeline Review, H2 2017, provides an overview of the Gouty Arthritis (Gout) (Musculoskeletal Disorders) pipeline landscape. Gout...

  • Chronic Disease
  • Musculoskeletal Disorder
  • Therapy
  • United States
  • Product Initiative
  • CYMABAY THERAPEUTICS INC
  • GOUTY ARTHRITIS (GOUT) - PIPELINE BY GENENTECH INC, H1 2018

Its products are used to treat multiple sclerosis, sepsis shock, HIV AIDS, rheumatoid arthritis, Crohn' s disease and psoriasis.

  • Musculoskeletal Disorder
  • Therapy
  • United States
  • Product Initiative
  • CymaBay Therapeutics, Inc.
  • DORMANT PRODUCTS, H1 2017 (CONTD..1), H1 2017
  • DORMANT PRODUCTS, H1 2018 (CONTD..1), H1 2018

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Cytokine
  • Musculoskeletal Disorder
  • United Kingdom
  • World
  • Product Initiative

It develops gene-based drugs that cure liver cancer, HIV, AIDS, Parkinson' s disease, and diabetes.

  • Musculoskeletal Disorder
  • Therapy
  • United States
  • Product Initiative
  • Pluristem Therapeutics Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Musculoskeletal Disorder
  • Pharmaceutical
  • World
  • Product Initiative
  • DORMANT PRODUCTS, H2 2017 (CONTD..1), H2 2017

The molecules developed by companies in Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ## and ## respectively.

  • Cytokine
  • Musculoskeletal Disorder
  • Therapy
  • World
  • Product Initiative

Patients were randomized ##:##:## to receive ## mg of emricasan, ## mg of emricasan, or placebo twice daily for ## weeks.

  • Clinical Trial
  • Hepatitis
  • Musculoskeletal Disorder
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

Randomized Study with Polyunsaturated Fatty Acids N## Changes in Bone Mineral Densitometry HIV-infected Patients.

  • Chronic Disease
  • Clinical Trial
  • Musculoskeletal Disorder
  • World
  • Novartis AG

Its product line includes chemicallysynthesized drugs and biological products in the areas of cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/ AIDS and rheumatoid arthritis.

  • Chemokine
  • Hospital
  • Musculoskeletal Disorder
  • Therapy
  • ChemoCentryx, Inc.

Diagnosing HIV/ AIDS in the initial phase of infection provides better opportunities for treatment.

  • Breast Cancer
  • Musculoskeletal Disorder
  • North America
  • United States
  • Market Size

The prominent features of this report are - ##.

  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative

About QUANTA Flash Calprotectin Prestizia, a wholly-owned subsidiary of Theradiag, works on fundamental research projects with the aim of developing new diagnostic markers using its microRNA platform, in the fields of oncology (rectal and ovarian cancers) and HIV/ AIDS.

  • Clinical Trial
  • Musculoskeletal Disorder
  • Neurological Disorder
  • United States
  • Grifols, S.A.
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Drug Discovery And Development
  • Musculoskeletal Disorder
  • World
  • Product Initiative
  • Teijin Limited
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Boehringer Sohn AG & Co KG ## ## ## ## ## ## ## ## Amgen Inc ## ## ## ## ## ## ## ## Mylan NV ## ## ## ## ## ## ## ## Parexel International Corp ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Bristol-My

  • Arthritis
  • Musculoskeletal Disorder
  • World
  • Product Initiative
  • Pfizer Inc.
  • PIPELINE BY IMMUNE RESPONSE BIOPHARMA, INC., H2 2016

Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) targeted pipeline therapeutics. The...

  • Biotechnology
  • Hospital
  • Musculoskeletal Disorder
  • Therapy
  • Novartis AG

Its product line includes chemicallysynthesized drugs and biological products in the areas of cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/ AIDS and rheumatoid arthritis.

  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • United States
  • World
  • Product Initiative